Upstream Bio (UPB) Non-Current Assets (2023 - 2026)

Upstream Bio's Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 25.48% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 22.64% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, down 22.82% from the prior year.
• Non-Current Assets slipped to $1.8 million in Q1 2026 per UPB's latest filing, from $2.0 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $5.4 million in Q3 2024 and bottomed at $202000.0 in Q4 2023.
• The 4-year median for Non-Current Assets is $2.2 million (2025), against an average of $2.3 million.
• Across the five-year window, Non-Current Assets soared 1166.83% in 2024 and plunged 59.87% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $202000.0 in 2023, then surged by 1166.83% to $2.6 million in 2024, then decreased by 22.82% to $2.0 million in 2025, then retreated by 10.13% to $1.8 million in 2026.
• Per Business Quant, the three latest UPB Non-Current Assets figures stand at $1.8 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025).